Based on what was stated in the August seminars I expected growth to be somewhat better than it has been Q3 and anticipated for Q4. And I thought next year would likely be 65+%.
But they evidently expanded the VAC to include all indications, which means a wider number of pratices involved. Which means herding some cats.
To me the more expeditious approach would have been to limit the VAC to burns and traumatic wounds. That way you are only including trauma surgeons in the process. The rest would be done after you get sales from the new accounts.
Will simply take more time, but for a bigger payout we can hope.
The wait gets a bit tedious. Is what it is.
Ann: AVITA Medical Announces Preliminary 2023 Highlights, page-27
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.42 |
Change
0.010(0.41%) |
Mkt cap ! $160.4M | |||
| Open | High | Low | Value | Volume |
| $2.42 | $2.45 | $2.41 | $562.3K | 231.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 82002 | $2.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.43 | 16 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVH (ASX) Chart |